Director Shareholding

Evolution Group PLC 30 September 2003 THE EVOLUTION GROUP PLC The Evolution Group Plc ("the Company") announces that David Norwood, the chief executive of IP2IPO Group Plc ("IP2IPO"), has today sold 1,250,000 ordinary shares of 1p each in the capital of the Company (representing 0.51 per cent of the Company's issued share capital) at 80p per share. Following such sale Mr Norwood retains 3,080,995 ordinary shares of 1p each in the capital of Evolution (representing 1.25 per cent of the Company's issued share capital). Mr Norwood is a non-executive director of Evolution. It was announced this morning that it is proposed that the ordinary shares in IP2IPO, the intellectual property commercialisation business in which Evolution currently holds a 75.2% interest, be admitted to trading on the Alternative Investment Market of the London Stock Exchange Plc and that IP2IPO is seeking to raise £25 million net by way of a placing. Mr Norwood has indicated that it is his intention to apply all of the proceeds of sale of ordinary shares in the Company in subscribing £1 million for ordinary shares in IP2IPO as part of IP2IPO's placing. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Evgen Pharma (EVG)
UK 100

Latest directors dealings